Title:
ANTI-ROR1 ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2024/008112
Kind Code:
A1
Abstract:
Provided are antibodies and antigen-binding fragments thereof that recognize ROR1. In some embodiments, the antibodies provide a means of treating ROR1-positive cancer. In some embodiments, the antibodies are used to diagnose or image ROR1-positive cancer.
Inventors:
ZHAO JIANXUN (CN)
NIE CUI (CN)
WANG ZHENG (CN)
GAO YUE (CN)
ZHAO CHUCHU (CN)
ZHU GUANGBEI (CN)
HOU JIANHAO (CN)
YANG YUANYUAN (CN)
NIE CUI (CN)
WANG ZHENG (CN)
GAO YUE (CN)
ZHAO CHUCHU (CN)
ZHU GUANGBEI (CN)
HOU JIANHAO (CN)
YANG YUANYUAN (CN)
Application Number:
PCT/CN2023/105835
Publication Date:
January 11, 2024
Filing Date:
July 05, 2023
Export Citation:
Assignee:
NONA BIOSCIENCES SUZHOU CO LTD (CN)
International Classes:
A61K35/00; C07K16/28; A61K39/395
Domestic Patent References:
| WO2021159029A1 | 2021-08-12 | |||
| WO2022129622A1 | 2022-06-23 |
Foreign References:
| CN111670045A | 2020-09-15 | |||
| CN107428833A | 2017-12-01 | |||
| US20210069342A1 | 2021-03-11 |
Other References:
ZHAO YUMING, ZHANG DENGYANG, GUO YAO, LU BO, ZHAO ZHIZHUANG JOE, XU XIAOJUN, CHEN YUN: "Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies", FRONTIERS IN ONCOLOGY, FRONTIERS RESEARCH FOUNDATION, CH, vol. 11, 28 May 2021 (2021-05-28), CH , pages 680834, XP093126376, ISSN: 2234-943X, DOI: 10.3389/fonc.2021.680834
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
Download PDF: